|
|
Volumn 42, Issue 9, 2012, Pages 968-978
|
|
Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIMALARIAL AGENT;
CHLOROQUINE;
HYDROXYCHLOROQUINE;
IMMUNOLOGIC FACTOR;
PROTON PUMP INHIBITOR;
BIOLOGICAL MODEL;
CARBOHYDRATE METABOLISM;
CARDIOVASCULAR DISEASES;
CHEMICALLY INDUCED;
CLINICAL TRIAL (TOPIC);
COHORT ANALYSIS;
COMPLICATION;
DOUBLE BLIND PROCEDURE;
DRUG EFFECTS;
DRUG ERUPTIONS;
DRUG INTERACTION;
FEMALE;
FETUS;
GASTROINTESTINAL DISEASE;
HUMAN;
LACTATION;
LIPID METABOLISM;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
LUPUS NEPHRITIS;
MALE;
PREGNANCY;
PREGNANCY COMPLICATIONS;
RETINA DISEASE;
ULTRAVIOLET RADIATION;
ANTIMALARIALS;
CARBOHYDRATE METABOLISM;
CARDIOVASCULAR DISEASES;
CHLOROQUINE;
CLINICAL TRIALS AS TOPIC;
COHORT STUDIES;
DOUBLE-BLIND METHOD;
DRUG ERUPTIONS;
DRUG INTERACTIONS;
FEMALE;
FETUS;
GASTROINTESTINAL DISEASES;
HUMANS;
HYDROXYCHLOROQUINE;
IMMUNOLOGIC FACTORS;
LACTATION;
LIPID METABOLISM;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
LUPUS NEPHRITIS;
MALE;
MODELS, BIOLOGICAL;
PREGNANCY;
PREGNANCY COMPLICATIONS;
PROTON PUMP INHIBITORS;
RETINAL DISEASES;
ULTRAVIOLET RAYS;
|
|
EID: 84875282770
PISSN: None
EISSN: 14455994
Source Type: Journal
DOI: 10.1111/j.1445-5994.2012.02886.x Document Type: Review |
|
Times cited : (83)
|
|
References (0)
|
